Related Experiment Video
Updated: Aug 10, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Cytoplasmic function of mutant promyelocytic leukemia (PML) and PML-retinoic acid receptor-alpha
Cristian Bellodi1, Karin Kindle, Francesca Bernassola
1Medical Research Council Toxicology Unit, Leicester LE1 9HN, United Kingdom.
Abstract:
The promyelocytic leukemia (PML) tumor suppressor of acute promyelocytic leukemia (APL) regulates major apoptotic and growth-suppressive pathways. In APL, PML is involved in a chromosomal translocation generating the PML-retinoic acid receptor-alpha (RARalpha) fusion protein. Two missense mutations in the remaining PML alleles have been identified, which give rise to a truncated cytoplasmic PML protein (Mut PML). APL patients carrying these mutations display resistance to retinoic acid (RA) and very poor prognosis. Here we show that Mut PML associates with the cytoplasmic regions we refer to as PML-cytoplasmic bodies (PML-CBs). Mut PML interacts with PML-RARalpha in PML-CB and potentiates PML-RARalpha-mediated inhibition of RA-dependent transcription. Remarkably, Mut PML stabilizes PML-RARalpha and inhibits differentiation induced by pharmacological doses of RA. A mutant form of PML-RARalpha that accumulates in the cytoplasm inhibits RA-dependent transcription and differentiation, thus suggesting that cytoplasmic localization of PML-RARalpha may contribute to transformation. Finally, we show that the bcr3 PML-RARalpha form is predominantly cytoplasmic and accumulates in PML-CBs. Taken together, these findings reveal novel insights into the molecular mechanisms contributing to APL.
Insights
Mutant promyelocytic leukemia (PML) proteins disrupt retinoic acid (RA) signaling in acute promyelocytic leukemia (APL). These mutations stabilize the PML-RARalpha fusion protein, inhibiting crucial differentiation pathways and worsening patient prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The promyelocytic leukemia (PML) protein is a tumor suppressor crucial for regulating apoptosis and growth suppression.
- In acute promyelocytic leukemia (APL), PML is aberrantly fused with retinoic acid receptor-alpha (RARalpha) due to chromosomal translocation.
- Specific missense mutations in PML alleles lead to a truncated, cytoplasmic form (Mut PML), associated with retinoic acid resistance and poor prognosis in APL patients.
Purpose of the Study:
- To investigate the role of Mut PML in the pathogenesis of APL.
- To elucidate the molecular mechanisms by which Mut PML affects PML-RARalpha function and retinoic acid (RA) signaling.
- To explore the significance of cytoplasmic localization of PML-RARalpha in APL transformation.
Main Methods:
- Co-immunoprecipitation assays to study protein interactions.
- Immunofluorescence microscopy to visualize protein localization in PML-cytoplasmic bodies (PML-CBs).
- Reporter gene assays to assess transcriptional activity.
- Cell differentiation assays in response to retinoic acid (RA).
Main Results:
- Mut PML localizes to cytoplasmic PML-CBs and interacts with PML-RARalpha within these bodies.
- Mut PML potentiates PML-RARalpha-mediated inhibition of RA-dependent transcription.
- Mut PML stabilizes PML-RARalpha, thereby inhibiting RA-induced differentiation and contributing to APL progression.
- A cytoplasmically localized mutant of PML-RARalpha inhibits RA-dependent transcription and differentiation, suggesting a role in transformation.
- The bcr3 PML-RARalpha isoform is predominantly cytoplasmic and localizes to PML-CBs.
Conclusions:
- Mut PML plays a critical role in APL pathogenesis by interfering with RA signaling and promoting cellular transformation.
- Cytoplasmic sequestration of PML-RARalpha, particularly in PML-CBs, is a key mechanism contributing to APL.
- These findings offer novel molecular insights into APL development and suggest potential therapeutic targets.
Related Concept Videos
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Regulation of Nuclear Protein Sorting
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Negative Regulator Molecules

